Please use this identifier to cite or link to this item:
https://hdl.handle.net/10216/153798Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.creator | Quispe, C | |
| dc.creator | Martins, N | |
| dc.creator | Manca, ML | |
| dc.creator | Manconi, M | |
| dc.creator | Sytar, O | |
| dc.creator | Hudz, N | |
| dc.creator | Shanaida, M | |
| dc.creator | Kumar, M | |
| dc.creator | Taheri, Y | |
| dc.creator | Martorell, M | |
| dc.creator | Sharifi-Rad, J | |
| dc.creator | Pintus, G | |
| dc.creator | Cho, WC | |
| dc.date.accessioned | 2023-11-08T09:57:49Z | - |
| dc.date.available | 2023-11-08T09:57:49Z | - |
| dc.date.issued | 2021 | |
| dc.identifier.issn | 1942-0900 | |
| dc.identifier.uri | https://hdl.handle.net/10216/153798 | - |
| dc.description.abstract | Due to its vast therapeutic potential, the plant-derived polyphenol curcumin is utilized in an ever-growing number of health-related applications. Here, we report the extraction methodologies, therapeutic properties, advantages and disadvantages linked to curcumin employment, and the new strategies addressed to improve its effectiveness by employing advanced nanocarriers. The emerging nanotechnology applications used to enhance CUR bioavailability and its targeted delivery in specific pathological conditions are collected and discussed. In particular, new aspects concerning the main strategic nanocarriers employed for treating inflammation and oxidative stress-related diseases are reported and discussed, with specific emphasis on those topically employed in conditions such as wounds, arthritis, or psoriasis and others used in pathologies such as bowel (colitis), neurodegenerative (Alzheimer's or dementia), cardiovascular (atherosclerosis), and lung (asthma and chronic obstructive pulmonary disease) diseases. A brief overview of the relevant clinical trials is also included. We believe the review can provide the readers with an overview of the nanostrategies currently employed to improve CUR therapeutic applications in the highlighted pathological conditions. | |
| dc.description.sponsorship | N.C.-M. acknowledges the Portuguese Foundation for Science and Technology under the Horizon 2020 Program (PTDC/PSI-GER/28076/2017). This work was supported by the CONICYT PIA/APOYO CCTE AFB170007, Seed #2001050151 and Collaborative #2101050160—University of Sharjah and Fondo di Ateneo per la Ricerca 2020, University of Sassari. | |
| dc.language.iso | eng | |
| dc.publisher | Hindawi | |
| dc.relation.ispartof | Oxidative Medicine and Cellular Longevity, vol.2021:3149223 | |
| dc.rights | openAccess | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
| dc.subject.mesh | Arthritis / drug therapy | |
| dc.subject.mesh | Arthritis / pathology | |
| dc.subject.mesh | Biological Availability | |
| dc.subject.mesh | Curcumin / chemistry | |
| dc.subject.mesh | Curcumin / therapeutic use | |
| dc.subject.mesh | Drug Carriers / chemistry | |
| dc.subject.mesh | Drug Stability | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Nanotechnology | |
| dc.subject.mesh | Neurodegenerative Diseases / drug therapy | |
| dc.subject.mesh | Neurodegenerative Diseases / pathology | |
| dc.subject.mesh | Plants, Medicinal / chemistry | |
| dc.subject.mesh | Plants, Medicinal / metabolism | |
| dc.title | Nano-Derived Therapeutic Formulations with Curcumin in Inflammation-Related Diseases | |
| dc.type | Artigo em Revista Científica Internacional | |
| dc.contributor.uporto | Instituto de Investigação e Inovação em Saúde | |
| dc.identifier.doi | 10.1155/2021/3149223 | |
| dc.relation.publisherversion | https://www.hindawi.com/journals/omcl/2021/3149223/ | |
| Appears in Collections: | I3S - Artigo em Revista Científica Internacional | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 10.1155-2021-3149223.pdf | 1.27 MB | Adobe PDF | ![]() View/Open |
This item is licensed under a Creative Commons License
